Cognito Therapeutics today announced the appointment of four new executives to accelerate its growth and commercialization ...
Cognito Therapeutics “As Cognito nears completion of enrollment in our pivotal HOPE trial and prepares for regulatory ...
Cognito Therapeutics, a neurotechnology company advancing disease-modifying therapies to treat CNS diseases, today announced ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback